M. Ychou 1 , F. Desseigne 2 , R. Guimbaud 3 , M. Ducreux 4 , O. Bouché 5 ,
RANDOMIZED PHASE II TRIAL COMPARING FOLFIRINOX (5FU/LEUCOVORIN, IRINOTECAN AND OXALIPLATIN) VS GEMCITABINE AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC.
Thomas C. Rindflesch, Ph.D., FACMI Lister Hill National Center for Biomedical Communications.
Semantic MEDLINE: An advanced Information Management Application for Biomedicine
Thomas C. Rindflesch, Ph.D., FACMI
